With over 30 years at the forefront of medical device technology, Owen Mumford understands that technologically advanced devices are only useful if patients use them.
As leaders in the design, development and delivery of self-injection devices, we continue to pioneer injection technologies to respond to changing patient needs.
Autoject® Micro is an example of a new technology developed from a demand for compact, discreet self-injection options. This compact design, which is the result of patented drive mechanism, offers patients convenience with storage, as well as portability. The smaller package also has the potential to lower cold store and logistics costs. The ergonomic design incorporates an oval shape and large grip detail on the cap to support less dexterous patients in treatment administration.3
In an effort to reduce the frequency of injections, more viscous and/or higher volume formulations are being investigated. Adapting a device to accommodate these requirements could mean an increase in device size. But as a result of its drive mechanism, Autoject® Micro can be readily adapted for use with more viscous solutions and/or higher volumes yet will remain a compact device. Furthermore, as a prefilled, single-use device, Autoject® Micro requires no assembly, making it easy to prepare and use.
For flexibility, the Autoject® Micro can be adapted for a range of conditions and multiple treatments. Not only does Autoject® Micro provide you with an adaptable platform, it is also capable of supporting two methods of activation. These features can provide patients with
a greater sense of control over their treatment – giving them confidence to take it
As well as convenience, the discreet Autoject® Micro offers true auto-injection. This means the needle is inserted and the dose is delivered easily to the injection site following activation. There is also a large viewing window and audible and visual feedback at the start and end of the dose, meaning patients can be confident their medication has been administered.3
Sharps injury prevention ensures the needle is hidden before and after use. As the needle is concealed, this can help reduce the anxiety associated with self-injectable devices.3
Owen Mumford understands how the right device and routine can positively influence adherence rates and help make treatments manageable and effective for your patients. Hence, Autoject® Micro has been designed to improve adherence by overcoming barriers to self-injection, providing a versatile platform that can be adapted for a range of conditions.
Visit omdevicesolutions.com to learn more about how Owen Mumford can meet your specific self-injection needs.